Cencora, Inc. (COR) stock
CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 14/3021% above fair value
$348.31−2.25 (-0.64%)
Close on Nov 18, 2026Market cap $66.47BP/E 25.9Yield 0.63%
Cencora free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Cencora's free cash flow for the twelve months ending Jun 30, 2026 was $4.06B, up 255.7% year over year. For fiscal 2025 it was $3.21B, up 7.0% from the year before. Over ten years it grew -1.4% a year on average. The highest annual figure on record is $3.69B in fiscal 2015.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $3.21B | +7.0% |
| FY2024 | Sep 30, 2024 | $3.00B | -13.2% |
| FY2023 | Sep 30, 2023 | $3.45B | +56.5% |
| FY2022 | Sep 30, 2022 | $2.21B | -1.0% |
| FY2021 | Sep 30, 2021 | $2.23B | +21.3% |
| FY2020 | Sep 30, 2020 | $1.84B | -9.7% |
| FY2019 | Sep 30, 2019 | $2.03B | +89.2% |
| FY2018 | Sep 30, 2018 | $1.07B | +3.6% |
| FY2017 | Sep 30, 2017 | $1.04B | -61.8% |
| FY2016 | Sep 30, 2016 | $2.71B | -26.5% |
| FY2015 | Sep 30, 2015 | $3.69B | +207.5% |
| FY2014 | Sep 30, 2014 | $1.20B | +104.9% |
| FY2013 | Sep 30, 2013 | $585.68M | -50.0% |
| FY2012 | Sep 30, 2012 | $1.17B | +15.8% |
| FY2011 | Sep 30, 2011 | $1.01B | +8.5% |
| FY2010 | Sep 30, 2010 | $932.15M | +46.1% |
| FY2009 | Sep 30, 2009 | $637.93M | +6.4% |
| FY2008 | Sep 30, 2008 | $599.76M | -45.3% |
| FY2007 | Sep 30, 2007 | $1.10B | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $2.43B | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $1.17B | -63.6% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$2.42B | – |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $2.88B | +252.5% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$73.97M | -103.1% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $3.22B | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | -$2.82B | -448.3% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $818.06M | -50.5% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $2.36B | +268.3% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -$991.20M | -288.2% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $810.94M | +27.8% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $1.65B | +66.7% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $640.65M | +117.0% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $526.65M | +284.6% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $634.35M | -19.1% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $990.88M | +17.3% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $295.23M | -72.8% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $136.93M | – |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $783.72M | -6.4% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $845.01M | -28.4% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $1.09B | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | -$540.11M | -169.6% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $837.64M | +1009.4% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $1.18B | +99.0% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | -$194.62M | -139.0% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $775.82M | +43.1% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $75.51M | -81.1% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $593.37M | +2.8% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $498.59M | -33.0% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $542.11M | – |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $399.74M | – |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $577.29M | -55.1% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $743.74M | – |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | -$182.74M | -127.1% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | -$63.32M | – |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $1.29B | +7.1% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -$353.43M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $673.32M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -$567.64M | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $1.20B | – |
See a number that looks wrong?